Multicenter validation identifies soluble PD-L1 as a biomarker for risk stratification in scrub typhus, indicating its role in clinical outcomes.
= 0.082). sPD-L1 demonstrated a significant trend with increasing severity and showed superior performance to conventional markers in distinguishing patients with organ dysfunction. Receiver operating characteristic analysis of sPD-L1 levels at hospital admission confirmed high discriminatory power, with AUCs of 0.997 and 0.981 in the two validation cohorts. This multicenter study identified sPD-L1 as a potential early biomarker for early risk stratification of patients with scrub typhus. IMPORTANCE: , affects over one million people annually in the Asia-Pacific region, with an in-hospital mortality rate of more than 30% among patients with severe disease. Early identification of patients at high risk of progression to multi-organ failure remains a major clinical challenge. Timely risk stratification to identify high-risk patients is essential to prevent poor clinical outcomes. This study identifies soluble programmed death-ligand 1 as a potential early biomarker that distinguishes patients at risk of developing severe disease within the first week of hospitalization.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: